NQO1 and cancer: Among phase I DMEs, the most studied carbonyl-reducing enzyme in relation to SFN is NAD(P)H:quinone oxidoreductase 1 (NQO1, also known as quinone reductase), which is recognized as an antioxidant, chemoprotective, and cancer-preventive enzyme.